Sibel Health Secures $30 Million Funding and 7th FDA Clearance for ANNE® One Monitoring Platform

Sibel Health secures $30 million in equity financing, aiming to expedite the ANNE® One monitoring platform deployment following its 7th FDA 510(k) clearance. The platform's advanced wearable sensors support wireless vital signs monitoring and FDA clearance under the IEEE SDC 11073 standard, addressing the need for interoperability in healthcare.